Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MelaTech
AddedFeb 17, 2024
UpdatedJun 18, 2026
MelaTech

MelaTech

Angel

Melatech: A biotech firm harnessing melanin's power for human protection, warmth, and energy.

HQ
Baltimore, MD, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to harness melanin's unique properties, MelaTech is a biotechnology company focused on developing innovative solutions for human protection, warmth, and energy. The company specializes in scalable melanin bioproduction, offering products that leverage melanin’s radiation-shielding capabilities to protect humans and electronics, as well as its heat capture properties to enhance heating systems in cold climates. MelaTech aims to revolutionize biomaterials and renewable energy sectors by tapping into melanin’s potential.

MelaTech has attracted attention from notable investors and industry experts due to its groundbreaking approach to biotechnology. The company’s key achievements include the successful development of scalable melanin production methods and the creation of novel applications for melanin in various industries. By providing sustainable and efficient solutions, MelaTech is making a significant impact on global innovation in biomaterials and renewable energy, positioning itself as a leader in the biotech space.

MelaTech - Similar Companies

MeliBio logo

MeliBio

melibio.com

Mirá Biotech logo

Mirá Biotech

mirabio.co

Soltego logo

Soltego

soltego.com

Melanin Kapital logo

Melanin Kapital

melaninkapital.com

Melior Innovations logo

Melior Innovations

Mobius logo

Mobius

mobius.co

Carmolex logo

Carmolex

Solarea Bio logo

Solarea Bio

solareabio.com

Marli Technology Solutions logo

Marli Technology Solutions

marli.io

Mushroom Material logo

Mushroom Material

microTERRA logo

microTERRA

microterra.com.mx

NKA Bio logo

NKA Bio

nkabio.com

Greenfluidics logo

Greenfluidics

greenfluidics.com

Eolic Wall logo

Eolic Wall

eolicwall.com

BlackHedge logo

BlackHedge

blackhedge.io

MelaTech - Quick Facts

Who are MelaTech's competitors?

Companies similar to MelaTech include MeliBio, Mirá Biotech, Soltego and Melanin Kapital.

When was MelaTech founded?

MelaTech was founded in 2017.

Where is MelaTech's headquarters located?

MelaTech's headquarters is located in Baltimore, MD, US.

When was MelaTech's last funding round?

MelaTech's most recent funding round was for $5k (USD) in August 2023.

How much has MelaTech raised to-date?

As of Aug 23, 2023, MelaTech has raised a total of $5k (USD).

How many employees does MelaTech have?

MelaTech has 3 employees as of Feb 4, 2024.

MelaTech - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biomaterials
Tags
  • Cleantech
NAICS
  • 220000Utilities
  • 221000Utilities
  • 221100Electric Power Generation, Transmission and Distribution
SIC
  • 4900Electric, Gas, And Sanitary Services
  • 4910Electric Services
  • 4911Electric Services
Show 3 more industry codes
SIC
  • 1300Oil And Gas Extraction
  • 1380Oil And Gas Field Services
  • 1382Oil And Gas Field Exploration Services